Spyre Therapeutics Inc. Common Stock, SYRE

SYRE Spyre Therapeutics Inc. Common Stock

2026-10-23

-2.17%

v

4d

None

7671.6m

%

None

Biotechnology: Pharmaceutical Preparations

Biotechnology

Related: AMGN,GILD,REGN,VRTX,BIIB,MRNA,BMY,PFE,LLY,NVS